Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes.

(Acta neuropathologica, v145.6:851-855)
Read publication

Overview publication

TitleCorrection to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes.
Date2023-06-01
Issue nameActa neuropathologica
Issue numberv145.6:851-855
DOI10.1007/s00401-023-02577-x
PubMed37115209
AuthorsHoffmann L, Coras R, Kobow K, López-Rivera JA, Lal D, Leu C, Najm I, Nürnberg P, Herms J, Harter PN, Bien CG, Kalbhenn T, Müller M, Pieper T, Hartlieb T, Kudernatsch M, Hamer H, Brandner S, Rössler K, Blümcke I & Jabari S
Read Read publication